VRNA
Morgan Stanley’s Verona Pharma VRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.2M | Sell |
182,330
-1,441,797
| -89% | -$136M | ﹤0.01% | 2957 |
|
2025
Q1 | $103M | Buy |
1,624,127
+140,374
| +9% | +$8.91M | 0.01% | 1236 |
|
2024
Q4 | $68.9M | Buy |
1,483,753
+892,844
| +151% | +$41.5M | ﹤0.01% | 1546 |
|
2024
Q3 | $17M | Sell |
590,909
-273,122
| -32% | -$7.86M | ﹤0.01% | 2953 |
|
2024
Q2 | $12.5M | Buy |
864,031
+530,859
| +159% | +$7.68M | ﹤0.01% | 3146 |
|
2024
Q1 | $5.36M | Sell |
333,172
-629,220
| -65% | -$10.1M | ﹤0.01% | 3862 |
|
2023
Q4 | $19.1M | Buy |
962,392
+888,349
| +1,200% | +$17.7M | ﹤0.01% | 3385 |
|
2023
Q3 | $1.21M | Sell |
74,043
-6,885
| -9% | -$112K | ﹤0.01% | 4689 |
|
2023
Q2 | $1.71M | Sell |
80,928
-124,968
| -61% | -$2.64M | ﹤0.01% | 4517 |
|
2023
Q1 | $4.13M | Buy |
205,896
+34,778
| +20% | +$698K | ﹤0.01% | 3934 |
|
2022
Q4 | $4.47M | Buy |
171,118
+166,140
| +3,337% | +$4.34M | ﹤0.01% | 3847 |
|
2022
Q3 | $51K | Sell |
4,978
-4,807
| -49% | -$49.2K | ﹤0.01% | 6399 |
|
2022
Q2 | $41K | Buy |
9,785
+332
| +4% | +$1.39K | ﹤0.01% | 6696 |
|
2022
Q1 | $47K | Buy |
9,453
+2,185
| +30% | +$10.9K | ﹤0.01% | 6739 |
|
2021
Q4 | $48K | Sell |
7,268
-926
| -11% | -$6.12K | ﹤0.01% | 6835 |
|
2021
Q3 | $45K | Buy |
8,194
+4,520
| +123% | +$24.8K | ﹤0.01% | 6773 |
|
2021
Q2 | $24K | Buy |
3,674
+2,174
| +145% | +$14.2K | ﹤0.01% | 6948 |
|
2021
Q1 | $13K | Sell |
1,500
-128
| -8% | -$1.11K | ﹤0.01% | 6871 |
|
2020
Q4 | $12K | Buy |
1,628
+128
| +9% | +$943 | ﹤0.01% | 6593 |
|
2020
Q3 | $9K | Buy |
+1,500
| New | +$9K | ﹤0.01% | 6309 |
|
2019
Q2 | – | Sell |
-1
| Closed | – | – | 6753 |
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6711 |
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6744 |
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6812 |
|
2018
Q2 | $0 | Sell |
1
-200
| -100% | – | ﹤0.01% | 6760 |
|
2018
Q1 | $4K | Buy |
201
+186
| +1,240% | +$3.7K | ﹤0.01% | 6431 |
|
2017
Q4 | $0 | Buy |
15
+1
| +7% | – | ﹤0.01% | 6658 |
|
2017
Q3 | $0 | Buy |
+14
| New | – | ﹤0.01% | 6625 |
|